Pacific Center for Emerging Infectious Diseases Research

太平洋新发传染病研究中心

• 批准号: 9098820
• 负责人: RICHARD YANAGIHARA
• 金额: $ 115.5万
• 依托单位: UNIVERSITY OF HAWAII AT MANOA
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-07-01 至 2020-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9098820
• 关键词: Accounting; Affect; Animals; Area; Asia; Avian Influenza; Award; Basic Science; Bioinformatics; Biological Sciences; Biomedical Research; Businesses; Cellular Immunology; Center for Translational Science Activities; Centers of Research Excellence; China; Clinical Research; Collaborations; Communicable Diseases; Communities; Data; Development; Diagnostic; Diagnostic tests; Ebola virus; Economics; Emerging Communicable Diseases; Ensure; Epidemic; Epigenetic Process; Extramural Activities; Faculty; Fostering; Foundations; Funding; Future Generations; Genetic; Goals; Grant; Growth; Guinea; Hawaii; Hawaiian population; Health; Health Services Research; Human; Infectious Diseases Research; Institution; International; Investments; Liberia; Mentors; Microbiology; Middle East Respiratory Syndrome Coronavirus; Mission; Modeling; Molecular Immunology; Monitor; Movement; National Institute of General Medical Sciences; Nutritional; Pacific Island Americans; Pakistan; Parasites; Phase; Poliomyelitis; Population Growth; Positioning Attribute; Prevention; Preventive Medicine; Principal Investigator; Productivity; Public Health; Recruitment Activity; Research; Research Infrastructure; Research Personnel; Research Priority; Resource Sharing; Resources; Science; Scientist; Sierra Leone; Speed; Stream; System; Therapeutic; Training; Training Support; Training and Education; Translational Research; Triad Acrylic Resin; Tropical Medicine; United States National Institutes of Health; Universities; Urbanization; Vaccines; base; biobehavior; disease diagnosis; ethnic disadvantage; ethnic minority population; graduate student; higher education; improved; microbial; next generation; novel vaccines; operation; programs; public health relevance; research and development; social

 DESCRIPTION (provided by applicant): Established in 2003, the Pacific Center for Emerging Infectious Diseases Research, a translational science center of excellence supported by funding from the Centers of Biomedical Research Excellence (COBRE) component of the Institutional Development Award (IDeA) program, seeks to develop and deploy rapid diagnostics, improved therapeutics and affordable vaccines for new, emerging and re-emerging infectious diseases that disproportionately affect underserved communities in the Asia-Pacific region. The COBRE Center also seeks to increase the diversity of the biomedical research workforce by training and mentoring native Hawaiians and other underrepresented Pacific Islanders. Thus, the Center's mission is thoroughly consistent with that of the National Institute of General Medical Sciences, which is to support basic research that lays the foundation for advances in disease diagnosis, treatment and prevention, and to increase the diversity of the research workforce by supporting the training of the next generation of scientists (http://www.nigms.nih.gov/About/Pages/default.aspx). The principal objective of the Phase III COBRE for emerging infectious diseases is to enhance the conditions that accelerate the pace of scientific discovery, heighten research productivity and increase competitiveness for extramural funding. The objective will be achieved by (1) enhancing the growth and sustainability of the COBRE cores in biocontainment, bioinformatics, and molecular and cellular immunology, which are grounded in the triad of customized and collaborative service, research and development, and education and training; and (2) developing and implementing a COBRE Small Grants Program, without borders, that fosters collaborations and partnerships, promotes data and resource sharing, and provides additional opportunities for mentoring and specialized training across IDeA-funded centers in research aimed at improving human health. COBRE funding during Phases I and II has transformed the landscape for mentoring and training future generations of investigators and has provided state-of-the-art core resources for multi-disciplinary collaborative research on epidemic infectious diseases. At the institutional level, COBRE funding has spurred significant commitments to recruit and retain a new cadre of productive faculty, and such efforts will continue into Phase III. High-level upper-administrative institutional commitments will ensure the sustainability of the Center and its cores beyond the Phase III COBRE period.